Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

No reported Accounts Receivables figures are available to summarize.

Accounts Receivables history

Currency unavailable · from the cash flow

No Accounts Receivables data reported for this period type.

Accounts Receivables vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors
Accounts Receivables for LTGO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PCRXPacira BioSciences, Inc.LTM Mar 2026$20.87M USD+571.9%+72.9%2.8%
SCLXScilex Holding CompanyLTM Mar 2026$2.42M USD-48.1%—7.2%
COLLCollegium Pharmaceutical, Inc.LTM Mar 2026$60K USD-99.4%—0.0%
LTGOLatigo Biotherapeutics Inc.—— ———
Peer median (excluding LTGO) —-48.1%+72.9%2.8%

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.